- Home
- ALM vs DVAX Comparison
ALM vs DVAX Comparison
Compare ALM & DVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALM | DVAX |
|---|---|---|
| Founded | N/A | 1996 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Other Metals and Minerals | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.3B |
| IPO Year | N/A | 2004 |
Fundamental Metrics
Financial Performance| Metric | ALM | DVAX |
|---|---|---|
| Price | $6.77 | $10.80 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 4 |
| Target Price | $12.00 | ★ $26.50 |
| AVG Volume (30 Days) | ★ 2.3M | 1.5M |
| Earning Date | 11-03-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $21,591,798.00 | ★ $330,514,000.00 |
| Revenue This Year | $78.23 | $24.63 |
| Revenue Next Year | $214.84 | $15.85 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 7.50 | ★ 26.73 |
| 52 Week Low | $0.89 | $9.20 |
| 52 Week High | $10.68 | $14.63 |
Technical Indicators
Market Signals| Indicator | ALM | DVAX |
|---|---|---|
| Relative Strength Index (RSI) | 50.74 | 48.59 |
| Support Level | $6.40 | $10.71 |
| Resistance Level | $8.17 | $11.00 |
| Average True Range (ATR) | 0.49 | 0.26 |
| MACD | 0.05 | -0.06 |
| Stochastic Oscillator | 47.27 | 22.63 |
Price Performance
Historical ComparisonAbout ALM Almonty Industries Inc.
Almonty Industries Inc is engaged in the mining, processing, and shipping of tungsten concentrate from its Los Santos tungsten mine located near Salamanca, Spain - the Los Santos Mine, the processing and shipping of tungsten concentrate from its Panasqueira tin and tungsten mine in Covilha, Castelo Branco, Portugal - the Panasqueira Mine, the evaluation of its Valtreixal tin and tungsten mine project located in Western Spain in the province of Zamora - the Valtreixal Mine, as well as the exploration and evaluation of its Sangdong tungsten mine project located in Gangwon Province, Republic of Korea - the Sangdong Mine.
About DVAX Dynavax Technologies Corporation
Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.